Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of fluid...
Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
Peptic Ulcer Disease I: Introduction01:30

Peptic Ulcer Disease I: Introduction

Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
Peptic Ulcer Disease I: Introduction01:25

Peptic Ulcer Disease I: Introduction

Peptic ulcer disease (PUD) involves breaks in the gastrointestinal tract's mucosal lining, primarily in the stomach and duodenum, with less frequent occurrences in the lower esophagus or near the pylorus.Ulcers can be acute or chronic. Acute ulcers are short-lived with minimal inflammation and heal quickly after the irritant is removed. Chronic ulcers persist, may recur, and often cause scarring due to ongoing tissue damage. Superficial erosions affect only the mucosal layer and are called...
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Peptic Ulcer Disease II: Pathophysiology01:24

Peptic Ulcer Disease II: Pathophysiology

Peptic ulcer disease develops when protective mechanisms of the gastrointestinal mucosa are overwhelmed by harmful factors, leading to localized erosions in the stomach or proximal duodenum. The main causes are Helicobacter pylori infection and chronic use of nonsteroidal anti-inflammatory drugs (NSAIDs).Helicobacter pylori–Induced InjuryBacterial Adaptation and Colonization:H. pylori is a spiral, Gram-negative bacterium adapted to the acidic stomach. and transmitted through oral-oral or...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Thrombocytosis: Rapid Evidence Review.

American family physician·2026
Same author

Engaging Peer Mentors for Opportunity, Well-Being, and Equity Realization-A Leadership Intervention for Women in Academic Medicine.

Journal of women's health (2002)·2025
Same author

Familial Hypercholesterolemia: Screening, Diagnosis, and Treatment.

American family physician·2024
Same author

Civilian and Military Medical School Graduates' Readiness for Deployment: Areas of Strength and Opportunities for Growth.

Military medicine·2024
Same author

Novel Pharmacotherapies for Hyperlipidemia.

Primary care·2024
Same author

A Comparison of Uniformed Services University and Health Professions Scholarship Program Graduates' First Deployment Readiness.

Military medicine·2023

Related Experiment Video

Updated: Jun 19, 2026

Granulocyte-dependent Autoantibody-induced Skin Blistering
12:23

Granulocyte-dependent Autoantibody-induced Skin Blistering

Published on: October 12, 2012

Henoch-Schönlein purpura.

Brian V Reamy1, Pamela M Williams, Tammy J Lindsay

  • 1Department of Family Medicine at Uniformed Services University of Health Sciences in Bethesda, MD 20814, USA. breamy@usuhs.mil

American Family Physician
|October 13, 2009
PubMed
Summary
This summary is machine-generated.

Henoch-Schönlein purpura, a vasculitis affecting children and adults, often follows respiratory illness. Supportive care is typical, but corticosteroids may aid symptom resolution and prevent kidney issues.

More Related Videos

Harvest of Endothelial Cells from the Balloon Tips of Swan-Ganz Catheters after Right Heart Catheterization
07:45

Harvest of Endothelial Cells from the Balloon Tips of Swan-Ganz Catheters after Right Heart Catheterization

Published on: January 23, 2019

Supervised Machine Learning for Semi-Quantification of Extracellular DNA in Glomerulonephritis
09:16

Supervised Machine Learning for Semi-Quantification of Extracellular DNA in Glomerulonephritis

Published on: June 18, 2020

Related Experiment Videos

Last Updated: Jun 19, 2026

Granulocyte-dependent Autoantibody-induced Skin Blistering
12:23

Granulocyte-dependent Autoantibody-induced Skin Blistering

Published on: October 12, 2012

Harvest of Endothelial Cells from the Balloon Tips of Swan-Ganz Catheters after Right Heart Catheterization
07:45

Harvest of Endothelial Cells from the Balloon Tips of Swan-Ganz Catheters after Right Heart Catheterization

Published on: January 23, 2019

Supervised Machine Learning for Semi-Quantification of Extracellular DNA in Glomerulonephritis
09:16

Supervised Machine Learning for Semi-Quantification of Extracellular DNA in Glomerulonephritis

Published on: June 18, 2020

Area of Science:

  • Immunology
  • Rheumatology
  • Pediatrics

Background:

  • Henoch-Schönlein purpura (HSP) is an acute, systemic immune complex-mediated leukocytoclastic vasculitis.
  • It classically presents with palpable purpura, abdominal pain, and arthritis, often preceded by an upper respiratory infection.
  • While most common in children under 10, adults may face increased complications.

Purpose of the Study:

  • To summarize the clinical presentation, management, and prognosis of Henoch-Schönlein purpura.
  • To evaluate the role of corticosteroids in managing HSP symptoms and renal involvement.

Main Methods:

  • Review of clinical characteristics and treatment outcomes for Henoch-Schönlein purpura.
  • Analysis of data regarding the efficacy of supportive care and corticosteroid therapy.

Main Results:

  • All patients develop a purpuric rash; arthritis (75%), abdominal pain (60-65%), and renal disease (40-50%) are common.
  • Supportive treatment is primary, with spontaneous resolution in most cases (94% in children, 89% in adults).
  • Corticosteroids may reduce abdominal pain duration and the risk of persistent renal disease in children.

Conclusions:

  • Henoch-Schönlein purpura typically resolves spontaneously, necessitating supportive care.
  • Corticosteroid therapy can be beneficial for symptomatic relief and potentially mitigating renal complications.
  • Prognosis is largely determined by the severity of renal involvement, with end-stage renal disease occurring in 1-5% of patients.